Ranking results:

Past rankings:

2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	0	9.902.750	2.592.750		1
2015	0	8.366.433	1.764.963		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
EXEVIR BIO	1
GRANZER HEINZ ULRICH	1
KARLSRUHER INSTITUT FUER TECHNOLOGIE	1
LEK PHARMACEUTICALS D D	1
NATIONAL INSTITUTE OF CHEMISTRY	1
NATIONAL SYSTEMS	1
SANDOZ	1
UNIVERSITAET FUER BODENKULTUR WIEN	1
VIB VZW	1

Constancy:

Total number of partners: 9
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 9
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2021-12-01	ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2	XVR011 Phase 2	participant	9.902.750	4
2015-03-01	Next-generation biopharmaceutical downstream process	nextBioPharmDSP	participant	8.366.433	7

MILLIPORE SAS -